jetcityimage/iStock Editorial via Getty Images
Eli Lilly said its Q1 earnings report will include acquired IPR&D charges of approximately $111M on a pre-tax basis, amounting around $0.10 per share on a GAAP and adjusted basis.
The company’s Q1 report has not yet been finalized and actual results may differ from its preliminary estimates, according to a statement posted on its website.
Lilly is expected to release its Q1 earnings report on April 30.